Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Oral Manifestation Of Anemia"

18:33 EDT 28th July 2014 | BioPortfolio

Original Source: Oral Manifestations of Aplastic Anemia

The purposes of this study are threefold: 1) to evaluate the prevalence and risks of oral complications in patients with aplastic anemia; 2) to evaluate if oral problems in these patients can predict their response to treatment; and 3) to review complications of dental treatment in these patients in order to establish treatment guidelines. This study will be performed through a review of medical charts of 79 patients with aplastic anemia and 67 patients with schizophrenia who...

Matching Channels

Matching News

First Patients Enrolled into European CKD-Associated Anemia Trial

Astellas Pharma Europe Ltd. announced that the first European patients have been enrolled into the global ALPINE program being conducted in collaboration with FibroGen Inc., to investigate the safety...

Anemia company Akebia files for IPO

Akebia Therapeutics Inc. (Cambridge, Mass.) filed to raise up to $75 million in an IPO on NASDAQ underwritten by Morgan Stanley; Credit Suisse; UBS; and Nomura. Akebia is evaluating AKB-6548 in a Phas...

New Oral Compound Redresses Metabolic Abnormalities in CKD

A new oral iron compound significantly reduces serum phosphate and increases low iron stores in patients with chronic kidney disease (CKD) and anemia, early trial results show. Medscape Medical News

Vifor’s Ferinject reduces need for other anemia treatment

Vifor Pharma, a part of Switzerland-based Galenica Group which develops pharmaceutical products for the treatment of iron deficiency, has published results of its FIND-CKD study demonstrating that com...

Injectafer®

Class: Supportive Care Generic Name: ferric carboxymaltose (FER-ik kar-box-ee-MAWL-tose) injection Trade Name: Injectafer® For which conditions is this drug approved? Injectafer is indicated for the...

Anemia play Akebia sets IPO terms

Akebia Therapeutics Inc. (Cambridge, Mass.) amended its planned IPO on NASDAQ and is aiming to sell 4.9 million shares at $14-$17. At the $15.50 midpoint, the company would raise $76 million and be va...

SWI provides information about pathophysiological changes of brain after acute hemorrphagic anemia

Acute hemorrhagic anemia can decrease blood flow and oxygen supply to brain, and affect its physiological function. Detecting changes in brain function in patients with acute hemorrhagic anemia is hel...

Marker for Iron-Deficiency Anemia?

The iron regulatory hormone hepcidin may be a useful marker for identifying children with anemia who would benefit from iron supplementation, according to a study in African children (Pasricha S-R et...

Matching PubMed Articles

Oral manifestations and blood profile in patients with iron deficiency anemia.

Iron deficiency anemia (IDA) is the most common type of anemia. This study evaluated whether IDA patients had specific oral manifestations and a particular blood profile compared to normal controls.

The Occurrence of Iron-Deficiency Anemia in Children With Type 1 Diabetes.

A higher risk for iron deficiency, which can lead to anemia, has been noticed in children with early stages of type 1 diabetes. Anemia in diabetes is not uncommon and thus may contribute to disease co...

Long-term follow-up of Fanconi anemia: clinical manifestation and treatment outcome.

The aim of this study was to characterize Korean patients with Fanconi anemia (FA), which is a rare but very challenging genetic disease.

Is the acronym IRIDA acceptable for slow responders to iron in the presence of TMPRSS6 mutations?

Iron refractory iron deficiency anemia (IRIDA) is a recently described autosomal recessive disorder caused by mutations in TMPRSS6, the gene encoding matriptase-2. Patients have inappropriately high l...

A forgotten screening test for iron deficiency anemia: Oral iron absorption test.

In this study, we aimed to investigate the iron absorption defects using the oral iron absorption test (OIAT) in patients with iron deficiency anemia (IDA).

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement